UPSTREAM BIO, INC.

EDGAR

Market value

$156.49M

54,811,391 shares as of 2026-11-06, at $2.855 a share (UPB, IEX close on 2026-11-12) Primary-source evidence

Annual consolidated revenue for 2025: about USD 2.854M, using the latest reported figures. The previous period, 2024, was about USD 2.37M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
15 transactions, 15,061 shares
Sum of shares × price per share: 104,796.49

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-09-16 Sutherland Everett Rand S 2,095 5.49
  • 2026-09-16 Ambrose Allison S 485 5.49
  • 2026-09-16 Houghton Adam S 700 5.49
  • 2026-09-16 Deykin Aaron S 895 5.49
  • 2026-09-16 GRAY MICHAEL S 853 5.49

5% holders (Schedule 13D and 13G)

  • FMR LLC 6.9% SCHEDULE 13G/A 10/30/2026
  • Abigail P. Johnson 6.9% SCHEDULE 13G/A 10/30/2026
  • Decheng Capital Global Life Sciences Fund IV, L.P. 4.9% SCHEDULE 13G/A 09/30/2026

See all insider transactions

Latest quarter

Revenue

395 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

-10,982.03%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: -43379000 USD Source
  • Revenue: 395000 USD Source

Operating cash flow

-54.2 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -137703000 USD Source
  • Operating Cash Flow: -83473000 USD Source

Free cash flow

-54.2 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -137703000 USD Source
  • Operating Cash Flow: -83473000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
47.4 million USD Source
Exact value

47416000 USD

Long-term debt including current maturities
Not available
Shares outstanding
54.8 million shares Source
Exact value

54811391 shares

Reported share-count change

1.50% · 812 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 53999522 shares · 2025-09-30· Source
  • 54811391 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.87 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 2854000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 2186000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 1034000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 773000 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 395000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-164 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -143443000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -100984000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -40591000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -39702000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -41192000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-168 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -133275000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -102644000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -47852000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -83473000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -47852000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -137703000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -83473000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-10.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +20.4%

    Prior period

    USD 2.37 million

    –

    Current period

    USD 2.85 million

    –

    Exact inputs and evidence

    2854000 − 2370000 = 484000 USD

    2370000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    2854000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 80.64 million

    Prior period

    −USD 62.81 million

    –

    Current period

    −USD 143.44 million

    –

    Exact inputs and evidence

    -143443000 − -62806000 = -80637000 USD

    -62806000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -143443000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 74.1 million

    Prior period

    −USD 59.17 million

    –

    Current period

    −USD 133.28 million

    –

    Exact inputs and evidence

    -133275000 − -59172000 = -74103000 USD

    -59172000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -133275000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -67.7%

    Prior period

    USD 511,000

    –

    Current period

    USD 165,000

    –

    Exact inputs and evidence

    165000 − 511000 = -346000 USD

    511000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    165000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 2.85 million 100% of revenue
  • Operating costs Derived USD 163.22 million 5,719% of revenue
  • Operating income −USD 160.36 million −5,619% of revenue
  • Tax, interest and other Derived −USD 16.92 million −593% of revenue
  • Net income −USD 143.44 million −5,026% of revenue

Cash

  • Operating cash flow −USD 133.28 million −4,670% of revenue
  • Capital expenditure USD 165,000 5.8% of revenue
  • Free cash flow Derived −USD 133.44 million −4,676% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Operating loss: operating costs were 1,785% of revenue.
  • 2024 Operating loss: operating costs were 3,381% of revenue.
  • 2025 Operating loss: operating costs were 5,719% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-312380000 42494000 Derived -40114000 -19577000 Derived -20537000 -38070000 Derived
Source
2024 2024-01-01 – 2024-12-312370000 80134000 Derived -77764000 -14958000 Derived -62806000 -59683000 Derived
Source
2025 2025-01-01 – 2025-12-312854000 163215000 Derived -160361000 -16918000 Derived -143443000 -133440000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.9M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.1M2.3M1.5M770.6K0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue2380000
2024Revenue2370000
2025Revenue2854000

Revenue growth

Change in revenue from the same financial period one year earlier.

20.4% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.22.1%16.0%10.0%4.0%-2.1%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year-0.4%
2025Year over year20.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -5,618.8% 2025
Net margin -5,026% 2025
Free cash flow margin -4,675.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.450%-1,180%-2,809%-4,439%-6,068%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-1,685.5%
2024Operating margin-3,281.2%
2025Operating margin-5,618.8%
2023Net margin-862.9%
2024Net margin-2,650%
2025Net margin-5,026%
2023Free cash flow margin-1,599.6%
2024Free cash flow margin-2,518.3%
2025Free cash flow margin-4,675.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -133.3M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.7M-28.0M-66.6M-105.3M-143.9M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow-37926000
2024Operating cash flow-59172000
2025Operating cash flow-133275000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -133.4M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.7M-28.0M-66.7M-105.4M-144.1M202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flow-38070000
2024Free cash flow-59683000
2025Free cash flow-133440000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

4% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.7%6.5%4.3%2.2%0.0%202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets8%
2024Liabilities / assets2.5%
2025Liabilities / assets4%

Current assets to current liabilities

Current assets divided by current liabilities.

26.15× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.48.20×36.15×24.10×12.05×0.00×202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities17.96×
2024Current assets / current liabilities44.63×
2025Current assets / current liabilities26.15×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
−USD 20.54 million
Exact value

Exact value: -20537000 USD

2023-01-01 – 2023-12-31: -20537000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.93 million
Exact value

Exact value: -37926000 USD

2023-01-01 – 2023-12-31: -37926000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 144,000
Exact value

Exact value: 144000 USD

2023-01-01 – 2023-12-31: 144000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 38.07 million
Calculation and evidence

-37926000 − 144000 USD

Exact free cash flow: -38070000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 62.81 million
Exact value

Exact value: -62806000 USD

2024-01-01 – 2024-12-31: -62806000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 59.17 million
Exact value

Exact value: -59172000 USD

2024-01-01 – 2024-12-31: -59172000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 511,000
Exact value

Exact value: 511000 USD

2024-01-01 – 2024-12-31: 511000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 59.68 million
Calculation and evidence

-59172000 − 511000 USD

Exact free cash flow: -59683000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 143.44 million
Exact value

Exact value: -143443000 USD

2025-01-01 – 2025-12-31: -143443000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 133.28 million
Exact value

Exact value: -133275000 USD

2025-01-01 – 2025-12-31: -133275000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 165,000
Exact value

Exact value: 165000 USD

2025-01-01 – 2025-12-31: 165000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 133.44 million
Calculation and evidence

-133275000 − 165000 USD

Exact free cash flow: -133440000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 772 latest values · 772 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002022626, 2022626, UPB, edgar:2022626

Also known as UPSTREAM BIO, INC., Upstream Bio, Inc.